You are here: Industry Insights > COVID-19

News List

Germany approves trials of COVID-19 vaccine candidate expresspharma
April 23, 2020
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the P
AYUSH Ministry modifies EMR Scheme for short-term COVID-19 research expresspharma
April 23, 2020
The move seeks to support short-term research proposals to evaluate the role and impact of AYUSH interventions/medicines in prophylaxis and clinical management of COVID-19.
Blood-pressure drugs are in the crosshairs of COVID-19 research expresspharma
April 23, 2020
A disproportionate number of patients hospitalised by COVID-19, the disease caused by the virus, have high blood pressure.
COVID-19 highlighted vulnerabilities in medical manufacturing supply chain: Fitch expresspharma
April 23, 2020
As per the report, as trade war has heightened discussion over the national security implications of manufacturing new technologies abroad, COVID-19 has highlighted vulnerabilities in the medical manufacturing supply chain, most notably in the US.
Searefico Group: Donating 'Unique' Isolated Negative Pressure Rooms to fight against COVID-19 prnasia
April 22, 2020
On April 18, 2020, Searefico Group has donated the first Isolated Negative Pressure Room (INPR) to HCMC Department of Health.
UK COVID-19 vaccine to begin human testing pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.
Bayer partners with Population Health Research Institute on COVID-19 research pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.
COVID-19 pandemic spurs cyber-attacks on healthcare sector, says report europeanpharmaceuticalreview
April 22, 2020
According to new research, as the healthcare and pharma sector relies on IT throughout the COVID-19 pandemic, cyber-attacks will be inevitable.
Trial finds lopinavir/ritonavir and Arbidol ineffective for mild-to-moderate COVID-19 europeanpharmaceuticalreview
April 22, 2020
A Phase IV trial in 86 patients with mild-to-moderate COVID-19 has indicated that lopinavir/ritonavir (LPV/r) and Arbidol do not improve clinical outcomes.
BARDA to give Moderna up to $483 million for COVID-19 vaccine development europeanpharmaceuticalreview
April 22, 2020
The US Biomedical Advanced Research and Development Authority (BARDA) will fund Moderna’s COVID-19 vaccine candidate mRNA-1273 through Phase II and III clinical trials to FDA licensure.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page